Plain-English translation of NCT06069141 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether works better for treating early syphilis in people with HIV when combined with doxycycline, an oral antibiotic. Right now, is the standard treatment, but researchers want to know if adding the second medication improves healing. The study will follow participants for up to 48 weeks to see how well their bodies respond to treatment.
Early syphilis can be serious, especially for people living with HIV, and doctors want to make sure they're using the most effective treatment approach. This trial will help determine whether this medication combination leads to better outcomes than the standard treatment alone.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to receive one of two treatments: either a single injection of alone, or the same injection plus doxycycline pills taken twice daily for 7 days. You'll have follow-up visits at week 4, week 24, and week 48 where your blood will be tested to measure how well the treatment is working. The study runs through 2025 and involves about 688 participants total.
AI-generated summary from trial data · Aug 7, 2026 · Not medical advice
Taiwan